Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a complex and devastating disease with a poor long-term prognosis. While women are at increased risk for developing PAH, they exhibit superior right heart function and higher survival rates than men. Susceptibility to disease risk in PAH has been attributed,...
Main Authors: | Yanan Sun, Shreya Sangam, Qiang Guo, Jian Wang, Haiyang Tang, Stephen M. Black, Ankit A. Desai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.719058/full |
Similar Items
-
Sex Differences in Pulmonary Hypertension
by: Juan José Rodriguez-Arias, et al.
Published: (2021-10-01) -
A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism
by: Margaret R. MacLean, et al.
Published: (2022-07-01) -
The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension
by: Eleni Vrigkou, et al.
Published: (2022-02-01) -
Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension
by: Sweeney Lori, et al.
Published: (2009-09-01) -
Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex
by: Ketul R. Chaudhary, et al.
Published: (2021-08-01)